Skip to main content

Table 1 Niger's EPI Vaccine Characteristics *Vaccines not included in current EPI schedule

From: Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model

Expanded Programme on Immunization (EPI) Vaccine

Immunization schedule

Doses per person

Doses per vial

Packaged volume per dose (cm3)

Packaged volume per diluent (cm3)

Route of administration

Preferred storage

Source

Bacille Calmette-Guerin (BCG)

Birth

1

20

1.2

0.7

Intra-dermal

Refrigerator

[1113]

Diptheria-tetanus-pertussis-hepatitis B-haemophilus influenza type B (DTP-HepB-Hib)

6, 10, 14 weeks

3

1

16.8

None

Intra-muscular

Refrigerator

[1113]

Yellow Fever (YF)

9 months

1

10

2.5

6.0

Sub-cutaneous

Refrigerator

[1113]

Oral Polio Virus (OPV)

Birth, 6, 10, 14 weeks

4

20

1.0

None

Intra-muscular

Freezer

[1113]

Tetanus Toxoid (TT)

1st contact, 4 weeks, 6 months, 1 year

5

10

3.0

None

Intra-muscular

Refrigerator

[1113]

Measles (M)

9 months

1

10

2.6

0.5

Sub-cutaneous

Refrigerator

[1113]

Measles (M)*

9 months

1

5

5.2

0.5

Sub-cutaneous

Refrigerator

[1113]

Measles (M)*

9 months

1

2

13.1

0.5

Sub-cutaneous

Refrigerator

[1113]

Measles (M)*

9 months

1

1

26.1

0.5

Sub-cutaneous

Refrigerator

[1113]